Literature DB >> 5639533

The contributions of different age groups to the transmission of Onchocerciasis in a Cameroon forest village.

B O Duke, P J Moore.   

Abstract

Entities:  

Mesh:

Year:  1968        PMID: 5639533     DOI: 10.1016/0035-9203(68)90026-6

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  13 in total

1.  Modeling targeted ivermectin treatment for controlling river blindness.

Authors:  Eric M Poolman; Alison P Galvani
Journal:  Am J Trop Med Hyg       Date:  2006-11       Impact factor: 2.345

2.  Vaccines to combat river blindness: expression, selection and formulation of vaccines against infection with Onchocerca volvulus in a mouse model.

Authors:  Jessica A Hess; Bin Zhan; Sandra Bonne-Année; Jessica M Deckman; Maria Elena Bottazzi; Peter J Hotez; Thomas R Klei; Sara Lustigman; David Abraham
Journal:  Int J Parasitol       Date:  2014-06-05       Impact factor: 3.981

3.  Development of a recombinant antigen vaccine against infection with the filarial worm Onchocerca volvulus.

Authors:  D Abraham; O Leon; S Leon; S Lustigman
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

4.  Immunity to onchocerciasis: cells from putatively immune individuals produce enhanced levels of interleukin-5, gamma interferon, and granulocyte-macrophage colony-stimulating factor in response to Onchocerca volvulus larval and male worm antigens.

Authors:  P S Turaga; T J Tierney; K E Bennett; M C McCarthy; S C Simonek; P A Enyong; D W Moukatte; S Lustigman
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

5.  Differential cytokine and antibody responses to adult and larval stages of Onchocerca volvulus consistent with the development of concomitant immunity.

Authors:  Angus J MacDonald; Prasad S D Turaga; Carolyn Harmon-Brown; Tracy J Tierney; Kristine E Bennett; Maggie C McCarthy; Scott C Simonek; Peter A Enyong; Daniel W Moukatte; Sara Lustigman
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

6.  The Onchocerca volvulus cysteine proteinase inhibitor, Ov-CPI-2, is a target of protective antibody response that increases with age.

Authors:  Fidelis Cho-Ngwa; Jing Liu; Sara Lustigman
Journal:  PLoS Negl Trop Dis       Date:  2010-08-24

7.  The effects of drugs on Onchocerca volvulus. 1. Methods of assessment, population dynamics of the parasite and the effects of diethylcarbamazine.

Authors:  B O Duke
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

8.  Preliminary study on temporal variations in biting activity of Simulium damnosum s.l. in Abeokuta North LGA, Ogun State Nigeria.

Authors:  Akinola S Oluwole; Uwem F Ekpo; Chiedu F Mafiana; Clement O Adeofun; Olufunmilayo A Idowu
Journal:  Parasit Vectors       Date:  2009-11-16       Impact factor: 3.876

Review 9.  A research agenda for helminth diseases of humans: basic research and enabling technologies to support control and elimination of helminthiases.

Authors:  Sara Lustigman; Peter Geldhof; Warwick N Grant; Mike Y Osei-Atweneboana; Banchob Sripa; María-Gloria Basáñez
Journal:  PLoS Negl Trop Dis       Date:  2012-04-24

10.  Relationship between oral declaration on adherence to ivermectin treatment and parasitological indicators of onchocerciasis in an area of persistent transmission despite a decade of mass drug administration in Cameroon.

Authors:  Samuel Wanji; Jonas A Kengne-Ouafo; Mathias E Esum; Patrick W N Chounna; Bridget F Adzemye; Joan E E Eyong; Isaac Jato; Fabrice R Datchoua-Poutcheu; Raphael A Abong; Peter Enyong; David W Taylor
Journal:  Parasit Vectors       Date:  2015-12-30       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.